Alnylam Pharmaceuticals Inc R&D Day 2020 (Event 2) Transcript - Thomson StreetEvents

Alnylam Pharmaceuticals Inc R&D Day 2020 (Event 2) Transcript

Alnylam Pharmaceuticals Inc R&D Day 2020 (Event 2) Transcript - Thomson StreetEvents
Alnylam Pharmaceuticals Inc R&D Day 2020 (Event 2) Transcript
Published Dec 16, 2020
27 pages (20208 words) — Published Dec 16, 2020
Price US$ 54.00  |  Buy this Report Now

About This Report

  
Abstract:

Edited Transcript of ALNY.OQ corporate analyst meeting

  
Brief Excerpt:

...Good morning, and welcome to day 2 of our Virtual Alnylam R&D Day event. I'm Christine Lindenboom, Senior Vice President of investor relations and Corporate Communications at Alnylam. With me today are Dr. Arun Sanyal, Virginia Commonwealth University School of Medicine; and Josh Friedman, Senior Director of Clinical Research at Alnylam, who will discuss succeeding in NASH with genetically validated targets. Pushkal Garg, Chief Medical Officer at Alnylam, will cover progress from our earlier-stage clinical pipeline. Kevin Fitzgerald, Chief Scientific Officer at Alnylam, will discuss opportunities beyond the liver with RNAi therapeutics and we will close with an update on our path to a self-sustainable financial profile with Alnylam's CFO, Jeff Poulton. Before I hand it over to Josh Freeman, I'd like to start with a few brief comments. Today's event is expected to run until approximately noon eastern standard time. Akshay will moderate a Q&A session at the conclusion of the presentations....

  
Report Type:

Transcript

Source:
Thomson StreetEvents
Company:
Alnylam Pharmaceuticals Inc
Ticker
ALNY.OQ
Time
2:00pm GMT
Format:
PDF Adobe Acrobat
Buy Now

Alnylam Pharmaceuticals Inc Q4 2020 Earnings Call Summary – 2021-02-11 – US$ 54.00 – Edited Brief of ALNY.OQ earnings conference call or presentation 11-Feb-21 1:30pm GMT

Alnylam Pharmaceuticals Inc Q4 2020 Earnings Call Transcript – 2021-02-11 – US$ 54.00 – Edited Transcript of ALNY.OQ earnings conference call or presentation 11-Feb-21 1:30pm GMT

Alnylam Pharmaceuticals Inc at JPMorgan Healthcare Conference (Virtual) Transcript – 2021-01-11 – US$ 54.00 – Edited Transcript of ALNY.OQ presentation 11-Jan-21 1:20pm GMT

Alnylam Pharmaceuticals Inc to Discuss Topline HELIOS-A Phase 3 Results of Vutrisiran - Conference Call Summary – 2021-01-07 – US$ 54.00 – Edited Brief of ALNY.OQ conference call or presentation 7-Jan-21 1:00pm GMT

Alnylam Pharmaceuticals Inc to Discuss Topline HELIOS-A Phase 3 Results of Vutrisiran - Conference Call Transcript – 2021-01-07 – US$ 54.00 – Edited Transcript of ALNY.OQ conference call or presentation 7-Jan-21 1:00pm GMT

Alnylam Pharmaceuticals Inc R&D Day 2020 (Event 1) Transcript – 2020-12-15 – US$ 54.00 – Edited Transcript of ALNY.OQ corporate analyst meeting</ 15-Dec-20 2:00pm GMT

Alnylam Pharmaceuticals Inc at Nasdaq Virtual Investor Conference Transcript – 2020-12-04 – US$ 54.00 – Edited Transcript of ALNY.OQ presentation 4-Dec-20 4:00pm GMT

Alnylam Pharmaceuticals Inc to Discuss FDA Approval of OXLUMO (Lumasiran) Conference Call Summary – 2020-11-24 – US$ 54.00 – Edited Brief of ALNY.OQ conference call or presentation 24-Nov-20 1:00pm GMT

Alnylam Pharmaceuticals Inc to Discuss FDA Approval of OXLUMO (Lumasiran) Conference Call Transcript – 2020-11-24 – US$ 54.00 – Edited Transcript of ALNY.OQ conference call or presentation 24-Nov-20 1:00pm GMT

Alnylam Pharmaceuticals Inc at Stifel Virtual Healthcare Conference Transcript – 2020-11-16 – US$ 54.00 – Edited Transcript of ALNY.OQ presentation 16-Nov-20 7:00pm GMT

More from Thomson StreetEvents

Thomson StreetEvents—Thomson StreetEvents is a leading provider of Web-based solutions for the investment community, offering services that transform the way companies communicate and meet disclosure requirements while assisting investors in managing and leveraging this information. Thomson StreetEvents service offers institutional investors a one-stop solution for managing corporate disclosure information by aggregating conference calls, webcasts, transcripts, call summaries, and other financial information into a time-saving, efficiency tool.
Purchase Thomson StreetEvents' Transcripts (verbatim reports) and Briefs (call summaries) of earnings, guidance, M&A and other corporate calls directly through Alacra. Discounted prices apply to reports produced over two weeks ago.

About the Author


Cite this Report

  
MLA:
Thomson StreetEvents. "Alnylam Pharmaceuticals Inc R&D Day 2020 (Event 2) Transcript" Dec 16, 2020. Alacra Store. May 02, 2025. <http://www.alacrastore.com/thomson-streetevents-transcripts/Alnylam-Pharmaceuticals-Inc-R-D-Day-2020-Event-2-T13509471>
  
APA:
Thomson StreetEvents. (2020). Alnylam Pharmaceuticals Inc R&D Day 2020 (Event 2) Transcript Dec 16, 2020. New York, NY: Alacra Store. Retrieved May 02, 2025 from <http://www.alacrastore.com/thomson-streetevents-transcripts/Alnylam-Pharmaceuticals-Inc-R-D-Day-2020-Event-2-T13509471>
  
US$ 54.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Credit Research from one place.